Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
We participate in a number of novel MS drug therapy clinical trials, including both phase II and phase III studies. A phase II study is typically only six to 10 months in duration, whereas a phase III study is a large multi-center clinical trial requiring a typical patient commitment of two years.
To inquire about participating in an ongoing clinical trial at the Judith Jaffe MS Center, please call our research coordinator: (646) 962-5736.
The MRI Database is a large-scale initiative to develop and evaluate novel methods to use MRI as a biomarker in multiple sclerosis. A collaborative effort with a team consisting of neuroradiologists, computer scientists, physicists and clinicians from the MS Center, this project will allow us to gain more insight into MS by tracking various pathological changes over time. With the implementation of novel MRI algorithms, investigators will be able to identify the specific variables associated with the progression of the disease, as well as facilitate the collection of longitudinal data on treatment.
The Judith Jaffe Multiple Sclerosis Clinical Database is supported by the Clinical and Translational Science Center (CTSC) at Weill Cornell Medical College. A secure online application (REDCap) designed exclusively to support data capture for research studies allows investigators to correlate clinical and epidemiological variables to specific MRI features of the disease.
Our goal is to combine the data from the Clinical and MRI Databases to further our understanding of the disease course, validate novel MRI biomarkers and create treatment algorithms based upon predictive modeling.